Trial Profile
A Phase II trial of OP-02 as a treatment to prevent recurrent acute otitis media (RAOM) in children
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 16 Sep 2018
Price :
$35
*
At a glance
- Drugs Cholesteryl palmitate/colfosceril palmitate (Primary)
- Indications Otitis media
- Focus Adverse reactions; Therapeutic Use
- 16 Sep 2018 New trial record